We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Pfizer and BioNTech Seek Authorization of a Second Booster Shot for Older Americans
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Politics > Pfizer and BioNTech Seek Authorization of a Second Booster Shot for Older Americans
Pfizer and BioNTech Seek Authorization of a Second Booster Shot for Older Americans
Politics

Pfizer and BioNTech Seek Authorization of a Second Booster Shot for Older Americans

Last updated: March 16, 2022 5:00 am
Editorial Board Published March 16, 2022
Share
SHARE
15dc pfizer 1 facebookJumbo

But since Israel only recently began its second booster program, researchers could not determine whether the added protection was short-lived. Israel began offering fourth doses to health care workers in late December, then quickly broadened eligibility to those 60 and older and other vulnerable groups.

Updated 

March 15, 2022, 9:06 p.m. ET

The second study, of Israeli health care workers, showed that even though fourth shots of either Pfizer’s or Moderna’s vaccine boosted antibody levels, they were not very effective at preventing infections. Researchers said those findings underscored the urgency of developing vaccines that target whatever variant is circulating.

The National Institutes of Health in the United States and various vaccine manufacturers have been studying how the vaccines could be updated. One federal health official said results were not expected until the summer.

Some senior administration officials say that depending on the evidence, a second booster could make sense now for older Americans, but not for the general population. The F.D.A. is expected to convene a meeting of its expert advisory committee next month to discuss the issue of fourth shots. Developments on Pfizer’s request were reported earlier by The Washington Post.

Asked last month whether everyone would need another injection, Dr. Peter Marks, the F.D.A.’s top vaccine regulator, said, “Barring any surprises from new variants, maybe the best thing is to think about our booster strategy in conjunction with the influenza vaccine next fall, and get as many people as possible boosted then.” Dr. Anthony S. Fauci, the chief medical adviser to the White House, has suggested that any move toward a second booster now would most likely be aimed at those most at risk, possibly based on age and underlying conditions.

To date, about two-thirds of Americans 5 and older have been fully vaccinated with two shots of a vaccine. Only about half of those eligible for boosters have received them, but the proportion rises to two-thirds for those 65 and older, according to the Centers for Disease Control and Prevention.

In a call with reporters on Tuesday, senior administration officials said the administration was running short on funds for new doses. The administration has enough supply to manage a fourth shot for people 65 and older, one said, but could not expand that effort to everyone without more funding from Congress.

You Might Also Like

Trump heads to Texas as flooding demise toll rises and questions swirl

New PAC varieties to again Mamdani NYC mayoral bid as enterprise group rallies to defeat him

State Division is firing over 1,300 staff beneath Trump administration plan

Texas AG Ken Paxton’s spouse recordsdata for divorce, citing infidelity

Days earlier than shedding to Mamdani, Cuomo pushed CFB to research him for alleged coordination

TAGGED:BioNTech SECenters for Disease Control and PreventionCoronavirus (2019-nCoV)ElderlyFood and Drug AdministrationNational Institutes of HealthPfizer IncResearchThe Washington MailVaccination and Immunization
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Key HIV care groups let go, placing moms and youngsters in danger
Health

Key HIV care groups let go, placing moms and youngsters in danger

Editorial Board April 10, 2025
Invoice Madden: Yankees’ major motive for AL East lead is the flawed groups behind them
Yankees experience Ben Rice’s grand slam to 12-2 win, take collection from A’s
Veterans of Carter-Era Inflation Warn That Biden Has Few Tools to Tame Prices
Prostate most cancers incidence, mortality charges primarily secure, lowering

You Might Also Like

Whistleblower backs up declare Trump official deliberate to defy choose’s order
Politics

Whistleblower backs up declare Trump official deliberate to defy choose’s order

July 10, 2025
Palestinian activist Mahmoud Khalil information M declare towards Trump administration
Politics

Palestinian activist Mahmoud Khalil information $20M declare towards Trump administration

July 10, 2025
Rep. Espaillat, influential amongst NYC Latino voters, endorses Zohran Mamdani for mayor
Politics

Rep. Espaillat, influential amongst NYC Latino voters, endorses Zohran Mamdani for mayor

July 10, 2025
Decide blocks Trump from ending birthright citizenship — once more
Politics

Decide blocks Trump from ending birthright citizenship — once more

July 10, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?